Cancer Theraphy with Radiolabeled Antibodies
Cancer Therapy with Radiolabeled Antibodies explores the most current experimental and clinical advances in the newly emerging field of cancer radioimmunotherapy (RAIT). Providing a multidisciplinary and international context, some of the world's leading experts examine the problems and prospec...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Boca Raton, FL
Taylor
2018 1995
|
| Series: | CRC Revivals
|
| Subjects: | |
| Online Access: | Click Here to View Status and Holdings. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Add Tag MARC
| LEADER | 00000nam a2200000#i 4501 | ||
|---|---|---|---|
| 001 | wils-944869 | ||
| 005 | 2019519123346 | ||
| 008 | t19952018 a 1 d | ||
| 020 | # | # | |a 9781315891309 |q hardback |
| 020 | # | # | |a 9780849351129 |q paperback |
| 020 | # | # | |a 084935112X |q paperback |
| 040 | # | # | |a DNLM |d UiTM |e rda |
| 041 | 0 | # | |a eng |
| 060 | 0 | 0 | |a WO 700 |
| 090 | 0 | 0 | |a WO700 |b C2146 2018 |
| 245 | 0 | 0 | |a Cancer Theraphy with Radiolabeled Antibodies |c edited by David M. Goldenberg |
| 264 | # | 1 | |a Boca Raton, FL |b Taylor |c 2018 |c 1995 |
| 264 | # | 4 | |c ©1995 |
| 300 | # | # | |a 326 pages |b illustration |c 26 cm |
| 336 | # | # | |a text |2 rdacontent |
| 337 | # | # | |a unmediated |2 rdamedia |
| 338 | # | # | |a volume |2 rdacarrier |
| 490 | 1 | # | |a CRC Revivals |
| 500 | # | # | |a Reissued 2018 by CRC Press |
| 504 | # | # | |a Includes bibliographical references and index |
| 520 | # | # | |a Cancer Therapy with Radiolabeled Antibodies explores the most current experimental and clinical advances in the newly emerging field of cancer radioimmunotherapy (RAIT). Providing a multidisciplinary and international context, some of the world's leading experts examine the problems and prospects of RAIT from radiation, immunological, chemical, physical, physiological, and clinical perspectives with both overviews and original research. Discussions cover the up-to-date clinical results in the RAIT of ovarian, breast, colorectal, and brain cancers, as well as the current status of RAIT in the management of B cell lymphomas. Radiobiology, dosimetry, radiochemistry, targeting biology in experimental models, clinical experiences in hematopoietic and solid tumors, and new approaches to improve cancer radioimmunotherapy are also discussed. In addition, new dosimetry concepts, new labeling methods, new concepts of antibody pharmacokinetics, and new methods to enhance selective cancer radioimmunotherapy are included |
| 650 | # | 2 | |a Radioimmunotherapy |x methods |
| 650 | # | 2 | |a Neoplasms |x radiotherapy |
| 700 | 1 | # | |a Goldenberg, David M. |d 1938- |e editor |
| 830 | # | 0 | |a CRC Revivals |
| 856 | 4 | 0 | |z Click Here to View Status and Holdings. |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=944869 |
| 998 | # | # | |a 00264#1a002.8.2||00264#1b002.8.4||00300##a003.4.1||00300##b003.6.1||00300##c003.5.1||00500##a002.17.2||00520##a007.2||00520##b007.2|| |
Targeted radionuclide therapy